June 2015 FDA Recall Drug by The Harvard Drug Group, Llc
D-1150-2015 - Superpotent Drug

This Class II drug recall was voluntarily initiated by The Harvard Drug Group, Llc on June 10, 2015 for the product Drug. The FDA reported the reason for recall as superpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1150-2015

Reason for Recall
Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl 5 mg tablets.
Initiated
06-10-2015
Reported
07-08-2015
Quantity
12,717 tablets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group, LLC
OXYCODONE HCl C-II Tablets, 5 mg USP, 100-count blister cards, Rx only, Manufactured by Nesher Pharmaceuticals USA LLC., St. Louis, MO 63044, Distributed by Major Pharmaceuticals, Livonia, MI 48150, NDC 0904-6444-61.

Batch or Lot Expiration Information

Lot# P-20000; Exp. 08/16
Lot# P-20004; Exp. 08/16